HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Targeted chemotherapy of visceral leishmaniasis by lactoferrin-appended amphotericin B-loaded nanoreservoir: in vitro and in vivo studies.

AbstractAIM:
Exploitation of lactoferrin-appended amphotericin B bearing nanoreservoir (LcfPGNP-AmB) for targeted eradication of Leishmania donovani.
MATERIALS & METHODS:
LcfPGNP-AmB was architechtured through ionic adsorption of lactoferrin over core poly (d,l-lactide-co-glycolide) nanoparticles and characterized. Anti-Leishmania activity in visceral leishmaniasis models, immunomodulatory potential, biodistribution and toxicity profile were also assessed.
RESULTS:
LcfPGNP-AmB (size, 196.0 ± 5.28 nm; zeta-potential, +21.7 ± 1.52 mV; encapsulation efficiency, ∼89%) showed reduced toxicity, increased protective proinflammatory mediators expression and down-regulation of disease-promoting cytokines. Biodistribution study illustrated preferential accumulation of LcfPGNP-AmB in liver and spleen. LcfPGNP-AmB showed augmented antileishmanial activity by significantly reducing (∼88%) splenic parasite burden of infected hamsters, compared with commercial-formulations.
CONCLUSION:
Superior efficacy, desired stability and reliable safety of cost-effective LcfPGNP-AmB, suggest its potential for leishmaniasis therapeutics.
AuthorsShalini Asthana, Pramod K Gupta, Anil K Jaiswal, Anuradha Dube, Manish K Chourasia
JournalNanomedicine (London, England) (Nanomedicine (Lond)) Vol. 10 Issue 7 Pg. 1093-109 ( 2015) ISSN: 1748-6963 [Electronic] England
PMID25929567 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Drug Carriers
  • Trypanocidal Agents
  • Amphotericin B
  • Lactoferrin
Topics
  • Amphotericin B (administration & dosage, pharmacokinetics, pharmacology, therapeutic use)
  • Animals
  • Cell Line
  • Cricetinae
  • Drug Carriers (chemistry, metabolism)
  • Drug Delivery Systems
  • Lactoferrin (chemistry, metabolism)
  • Leishmania donovani (drug effects)
  • Leishmaniasis, Visceral (drug therapy, parasitology)
  • Macrophages (parasitology)
  • Male
  • Mice
  • Nanoparticles (chemistry, metabolism, ultrastructure)
  • Rats, Wistar
  • Spleen (parasitology)
  • Tissue Distribution
  • Trypanocidal Agents (administration & dosage, pharmacokinetics, pharmacology, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: